Cargando…
Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
BACKGROUND: HMG Co-A reductase inhibitors are ubiquitous in our community yet their potential role in age-related macular degeneration (AMD) remains to be determined. METHODOLOGY/PRINCIPAL FINDINGS: Objectives: To evaluate the effect of simvastatin on AMD progression and the effect modification by p...
Autores principales: | Guymer, Robyn H., Baird, Paul N., Varsamidis, Mary, Busija, Lucy, Dimitrov, Peter N., Aung, Khin Zaw, Makeyeva, Galina A., Richardson, Andrea J., Lim, Lyndell, Robman, Liubov D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877099/ https://www.ncbi.nlm.nih.gov/pubmed/24391822 http://dx.doi.org/10.1371/journal.pone.0083759 |
Ejemplares similares
-
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Guymer, Robyn H, et al.
Publicado: (2008) -
Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study
por: Chong, Elaine W., et al.
Publicado: (2015) -
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
por: Robman, Liubov, et al.
Publicado: (2017) -
Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
por: Robman, Liubov D., et al.
Publicado: (2020) -
Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study
por: McCarty, Catherine A, et al.
Publicado: (2008)